Department of Pharmacognosy, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Daru. 2022 Jun;30(1):85-101. doi: 10.1007/s40199-022-00434-y. Epub 2022 Feb 23.
Daphne pontica is an endemic plant grown wild in the North part of Iran, with anticancer activities.
This study aims to analyze the phytochemistry and screen the cytotoxic activity of new bioactive compounds against a panel of cancer cells, in addition to proapototic properties against prostate cancer cells.
Purification procedure was done using repeated column chromatographies by MPLC and HPLC systems. The structures were elucidated by the NMR and exact mass spectroscopy, stereochemistry by NOESY, and absolute configuration by electronic circular dichroism (ECD) spectra. Cytotoxicity was done against DU 145, LNCaP, HeLa, MCF-7, and MDA-MB 231 cells by standard MTT assay. An annexin V/PI assay was performed to measure the type of death following treatment with these compounds for 48 h, followed by the caspase-3 activity test.
In this study, one new dilignan named lignopontin A (9), in addition to 13 known compounds including two phenolic acids (3, 5), one flavanone (6), one bis flavonoid (1), one cumarin glycoside (2), one mono (4) and two dicumarins (10, 11), two lignans (7, 8), and three daphnane diterpenoids (12-14) were isolated for the first time from D. pontica stems. Complete spectral data of compound 12, named as 6,7α-epoxy-5β-hydroxy-9,13,14-ortho-(4,2E)-pentadeca-2,4-diene-1-yl)-resiniferonol, and compound 14, named as 6,7α-epoxy-5β-hydroxy-9,3,14-ortho-(2,4E)-pentadeca-2,4-di-1-yl)-resiniferonol-12β-yl-acetate are reported for the first time. In the MTT assay of newly described compounds against a panel of cancer cells, compounds 9, 12, and 14 possessed moderate to potent cytotoxicity against prostate, breast, and cervical cancer cells in a dose-dependent manner. Flow cytometry analysis against prostate cancer cells indicated that the cytotoxicity of compounds 12 and 14 was due to their ability to induce apoptosis. In the case of compound 9, in Du 145 cells, cell death was mainly through apoptosis. In contrast, LNCaP cells showed both apoptosis and necrotic cell death, predominated by necrosis at the higher concentrations. Caspase-3 activity confirmed apoptosis observed in these compounds through the caspase pathway in prostate cancer cells.
D. pontica is a new source of dimeric phenolic compounds, including bisflavonoids, phenylpropanoid-cumarin adduct, and dilignans, as well as daphnane diterpenoids with resiniferonol core with long-chain orthoester moieties. In cytotoxicity screening, compounds 9, 12, and 14 inhibited the growth of DU-145 and LNCaP cells in a dose-dependent manner with IC varied from 0.9 - 27.3 and 25.2 - 87.4 μM, respectively. Among them, 9 exhibited selective growth inhibition against DU 145 treated cells. LNCaP cells demonstrated the highest sensitivity to treatment with compound 12.
Daphne pontica 是一种生长在伊朗北部的特有植物,具有抗癌活性。
本研究旨在分析其植物化学成分,筛选针对一系列癌细胞的新型生物活性化合物,并对前列腺癌细胞进行促凋亡作用分析。
采用 MPLC 和 HPLC 系统重复柱层析法进行纯化。通过 NMR 和精确质量光谱、NOESY 确定立体化学、电子圆二色性(ECD)光谱确定绝对构型,阐明结构。采用 MTT 法检测化合物对 DU 145、LNCaP、HeLa、MCF-7 和 MDA-MB 231 细胞的细胞毒性。通过 Annexin V/PI 检测,测定细胞死亡类型,随后进行 caspase-3 活性检测。
本研究首次从 D. pontica 茎部分离出一种新的二芳基木质素类化合物,命名为木质 pontin A(9),此外还分离出 13 种已知化合物,包括 2 种酚酸(3、5)、1 种黄烷酮(6)、1 种双黄酮(1)、1 种香豆素糖苷(2)、1 种单(4)和 2 种二蒽醌(10、11)、2 种木质素(7、8)和 3 种瑞香烷二萜(12-14)。首次报道了化合物 12 的完整光谱数据,命名为 6,7α-环氧-5β-羟基-9,13,14-ortho-(4,2E)-十五烷-2,4-二烯-1-基)-树脂醇和化合物 14,命名为 6,7α-环氧-5β-羟基-9,3,14-ortho-(2,4E)-十五烷-2,4-二烯-1-基)-树脂醇-12β-基-乙酸酯。新描述的化合物对一系列癌细胞的 MTT 检测结果表明,化合物 9、12 和 14 对前列腺癌、乳腺癌和宫颈癌均具有中等至较强的细胞毒性,呈剂量依赖性。针对前列腺癌细胞的流式细胞术分析表明,化合物 12 和 14 的细胞毒性与其诱导细胞凋亡的能力有关。在 9 号化合物的情况下,在 Du 145 细胞中,细胞死亡主要通过细胞凋亡。相比之下,LNCaP 细胞表现出凋亡和坏死性细胞死亡,在较高浓度下以坏死为主。caspase-3 活性通过 caspase 途径证实了这些化合物在前列腺癌细胞中的凋亡作用。
D. pontica 是二芳基酚类化合物的新来源,包括双黄酮、苯丙氨酸-香豆素加合物和木质素二聚体,以及具有树脂醇核心和长链邻酯基的瑞香烷二萜。在细胞毒性筛选中,化合物 9、12 和 14 以剂量依赖的方式抑制 DU-145 和 LNCaP 细胞的生长,IC 50 分别为 0.9-27.3、25.2-87.4 μM。其中,9 号化合物对 DU 145 处理的细胞表现出选择性生长抑制作用。LNCaP 细胞对化合物 12 的敏感性最高。